Corium International Company
Corium International engages in the development of advanced transdermal drug delivery technologies and products.
Employee Number:
501-1000
Funding Status:
M&A
Headquarters:
Menlo Park, California, United States
Technology:
Immunotherapy
Estimated Revenue:
$10M to $50M
Founded Date:
1995
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
PharmTech